NPM1-mutated AML: targeting by disassembling

Blood. 2011 Sep 15;118(11):2936-8. doi: 10.1182/blood-2011-07-366146.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Differentiation / drug effects*
  • Female
  • Humans
  • Nuclear Proteins / antagonists & inhibitors*
  • Nuclear Proteins / physiology*
  • Nucleophosmin

Substances

  • Antineoplastic Agents
  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin